{"id":"https://genegraph.clinicalgenome.org/r/1c12b166-0ed0-4aa3-8601-a2e077b17dadv1.0","type":"EvidenceStrengthAssertion","dc:description":"The *SMARCA1* gene encodes a member of the SWI/SNF family of proteins. Also known as SNF2L, the encoded protein is an ATPase which is expressed in diverse tissues and forms chromatin remodeling complexes with different partners to regulate transcription. In 2015, Karaca *et al.* reported a nonsense *SMARCA1* variant of unknown inheritance in a male with intellectual disability, microcephaly, spasticity, cortical atrophy, and Coffin-Siris-like dysmorphic features (PMID: 26539891). In 2016, a large exome study reported a *de novo* frameshift variant in a male patient with intellectual disability (PMID: 27479843). In addition, at least four missense variants have been reported in individuals with intellectual disability: a *de novo* variant in a female with a Rett syndromeâ€“like phenotype (PMID: 26740508), two *de novo* variants in individuals with developmental delay/intellectual disability (PMID: 33057194), and a maternally-inherited missense variant in two affected brothers (PMID: 27457812). While *SMARCA1* is highly intolerant to truncating variants (pLI 1, gnomAD v2.1.1), it is not significantly constrained for missense variants (Z = 2.44). Thus, in the absence of functional evidence of pathogenicity, none of the missense variants were scored.\n\nThis gene-disease relationship is supported by experimental evidence. SMARCA1 and BPTF are part of the human NURF complex, an ISWI-containing ATP-dependent chromatin-remodeling complex (PMID: 14609955); variants in *BPTF* are implicated in autosomal dominant syndromic intellectual disability. In addition, transfection of mouse neuroblastoma cells by wild type but not mutant SMARCA1 protein has been shown to promote neurite outgrowth (PMID: 14609955).\n\nIn summary, there is limited evidence at this time to support the relationship between *SMARCA1* and X-linked intellectual disability. Additional studies are required to verify this gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on August 3, 2022 (SOP Version 9). Please note: this gene was originally curated for Coffin-Siris syndrome by the General Gene Curation Expert Panel in 2016 and classified as Moderate. The current classification of Limited reflects updated scoring practices in SOP version 9 and the consensus of the ID/Autism Gene Curation Expert panel.\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/1c12b166-0ed0-4aa3-8601-a2e077b17dad","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ce97120a-5094-4768-b305-941353791584","calculatedEvidenceStrength":"Limited","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ce97120a-5094-4768-b305-941353791584_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2022-08-03T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/ce97120a-5094-4768-b305-941353791584_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2022-10-07T19:21:38.539Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce97120a-5094-4768-b305-941353791584_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3c43479-c0a9-4324-949c-b049013b3b5e","type":"EvidenceLine","dc:description":"Missense variant without functional studies, present in gnomAD (4x, including a male), other affected family members suggest that the pathogenic variant is not X-linked.","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f3c43479-c0a9-4324-949c-b049013b3b5e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27457812","allele":{"id":"https://genegraph.clinicalgenome.org/r/45b215f0-d897-42c4-a9ee-f87c529dc27c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001282874.2(SMARCA1):c.79G>A (p.Glu27Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA10511878"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/ce97120a-5094-4768-b305-941353791584_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b94e50bc-0648-4937-b8dc-711493b6471d_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27457812","rdfs:label":"PKMR142","family":{"id":"https://genegraph.clinicalgenome.org/r/b94e50bc-0648-4937-b8dc-711493b6471d","type":"Family","rdfs:label":"PKMR142","member":{"id":"https://genegraph.clinicalgenome.org/r/6c176a62-86c7-461f-965a-1826234d719a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27457812","rdfs:label":"Proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/45b215f0-d897-42c4-a9ee-f87c529dc27c"},"firstTestingMethod":"Exome sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/f3c43479-c0a9-4324-949c-b049013b3b5e_variant_evidence_item"}}},"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/6c176a62-86c7-461f-965a-1826234d719a"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/abde4e82-c745-4124-90b3-6341bb9d42f1","type":"EvidenceLine","dc:description":"SMARCA1 is not significantly constrained for missense variants (Z = 2.44). Thus, in the absence of functional evidence of pathogenicity, none of the missense variants were scored.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/abde4e82-c745-4124-90b3-6341bb9d42f1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33057194","allele":{"id":"https://genegraph.clinicalgenome.org/r/5c0eeeff-737e-479a-978d-6acc5a4d926f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001282874.2(SMARCA1):c.2422C>T (p.Arg808Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA335081535"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/f25f2100-b98a-433d-89ff-0f44df230910","type":"EvidenceLine","dc:description":"genetically heterogeneous phenotype","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f25f2100-b98a-433d-89ff-0f44df230910_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27479843","allele":{"id":"https://genegraph.clinicalgenome.org/r/37b9e6c6-5ef6-4ee9-adfc-20278d300763","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001282874.2(SMARCA1):c.2501dup (p.Ile835AspfsTer2)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA644171069"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/bc79fcc9-1dfa-4496-9c1b-9d2664184d4a","type":"EvidenceLine","dc:description":"SMARCA1 is not significantly constrained for missense variants (Z = 2.44). Thus, in the absence of functional evidence of pathogenicity, none of the missense variants were scored.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc79fcc9-1dfa-4496-9c1b-9d2664184d4a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26740508","allele":{"id":"https://genegraph.clinicalgenome.org/r/82e305cf-e318-4fe4-ac69-660bfbec9537","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001282874.2(SMARCA1):c.2933G>T (p.Gly978Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA501239"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/4f7ed236-c9b0-485a-a082-03afe9b8ecf8","type":"EvidenceLine","dc:description":"genetically heterogeneous phenotype","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4f7ed236-c9b0-485a-a082-03afe9b8ecf8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26539891","allele":{"id":"https://genegraph.clinicalgenome.org/r/078b6c0e-8169-46bc-85c1-37e94d1e7757","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001282874.2(SMARCA1):c.7C>T (p.Gln3Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA501238"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Hemizygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/71d5360a-5428-4c31-8fd4-72d69dc3b536","type":"EvidenceLine","dc:description":"SMARCA1 is not significantly constrained for missense variants (Z = 2.44). Thus, in the absence of functional evidence of pathogenicity, none of the missense variants were scored.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/71d5360a-5428-4c31-8fd4-72d69dc3b536_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33057194","allele":{"id":"https://genegraph.clinicalgenome.org/r/3886235f-6d7f-48dd-864c-e18c93c09841","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_001282874.2(SMARCA1):c.353C>T (p.Thr118Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA414549394"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ce97120a-5094-4768-b305-941353791584_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ce97120a-5094-4768-b305-941353791584_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c127a75-75bc-4494-9645-1d19ae01dd31","type":"EvidenceLine","dc:description":"Mice exhibit increased brain size whereas 1 patient with LoF variant reported by Karaca had microcephaly. In addition, FOXG1 is involved in disease through loss-of-function, whereas here the loss of Smarca1 results in increased FoxG1 expression.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90217ebf-f478-45ac-8c87-2312f9dc9f02","type":"Finding","dc:description":"Snf2l (Smarca1) mutant mice (hemizygous deletion of exon 6, encoding the ATP-binding domain) exhibit deregulated Foxg1 expression resulting in enhanced progenitor expansion, increased brain mass and cell density, and delayed differentiation.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/22516202","rdfs:label":"Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/c933d980-ea2e-4d61-8b6c-c247e8f81209","type":"EvidenceLine","dc:description":"The drosophila gene is orthologous to both human SMARCA1 and human SMARCA5.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41982789-c6e0-4524-9e0a-5fd5a5ad1a36","type":"Finding","dc:description":"LoF of the SMARCA5 Drosophila ortholog Iswi (orthologous to human SMARCA1 or SMARCA5) led to smaller body size, reduced sensory dendrite complexity, and tiling defects in larvae. In adult flies, Iswi neural knockdown caused decreased brain size, aberrant mushroom body morphology, dendrite and axon mispatterning, and abnormal locomotor function. Iswi LoF was rescued by wild-type but not mutant SMARCA5.\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/33980485","rdfs:label":"Fly Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/2a63b147-bdca-475a-82df-d889042b74e9","type":"EvidenceLine","dc:description":"A neuroblastoma cell line rather than neurons was used in this experiment. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e783c7f6-3382-421c-badc-160c8b97356c","type":"Finding","dc:description":"Cell culture phenotype suggests that SMARCA1 is important for neural development and brain function. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14609955","rdfs:label":"Mouse Cell Culture Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityCellCultureModelOrganismCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ce97120a-5094-4768-b305-941353791584_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f550744c-144d-421f-81e7-0ddb27296ff8","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/80bdc0db-af50-4b34-bd94-00e4237b657e","type":"Finding","dc:description":"BPTF is associated with syndromic intellectual disability (Definitive, curated by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on 7/6/2022).\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/14609955","rdfs:label":"Isolation of NURF, a complex formed by SMARCA1 and BPTF","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":1}],"evidenceStrength":"Limited","sequence":5183,"specifiedBy":"GeneValidityCriteria9","strengthScore":2,"subject":{"id":"https://genegraph.clinicalgenome.org/r/PmwI-kgSAfo","type":"GeneValidityProposition","disease":"obo:MONDO_0100284","gene":"hgnc:11097","modeOfInheritance":"obo:HP_0001417"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ce97120a-5094-4768-b305-941353791584-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}